TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/25/19 16:38 | 2/21/19 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Rubin Marc | GA | D | S.dm | -308 | 6.02 | 0 | -51 | -79 | 14 | D | |||||||||||||||
1/25/19 16:38 | 1/23/19 | CRIS | Curis Inc | DE | Health | BioPrd | Biological Products, (No Diag | Rubin Marc | MA | D | S | -19 | 1.05 | 0 | -19 | -39 | 29 | D | |||||||||||||||
9/6/18 16:24 | 9/4/18 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Rubin Marc | GA | D | S.d | -78 | 6.58 | 0 | -12 | -37 | 21 | D | |||||||||||||||
9/4/18 16:08 | 8/30/18 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Rubin Marc | GA | D | S.d | -353 | 6.08 | 0 | -58 | -69 | 26 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |